News | August 28, 2023
Gland Pharma receives 2 observations under 483 for Pashamylaram facility
The company is committed to address the observations and will submit its response to US FDA within the stipulated time
The company is committed to address the observations and will submit its response to US FDA within the stipulated time
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
Eris Lifesciences enters into term loan agreement with Citi Bank
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
Oteseconazole Capsules were found to be safe and more effective than fluconazole
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive brain stimulation technique approved by regulatory authorities, including the USFDA
Subscribe To Our Newsletter & Stay Updated
